NCT07094373 Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data Status RECRUITING Phase N/A
NCT07088068 A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes Status RECRUITING Phase PHASE3
NCT07086976 A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia Status RECRUITING Phase PHASE3
NCT07071558 Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age Status COMPLETED Phase PHASE1
NCT07053423 A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. Status RECRUITING Phase PHASE4
NCT07052396 Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions Status RECRUITING Phase N/A
NCT07038473 Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF) Status RECRUITING Phase NA
NCT07007962 Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment Status RECRUITING Phase PHASE3
NCT07002060 Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults Status COMPLETED Phase PHASE3
NCT07002047 Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany Status COMPLETED Phase N/A
NCT06984627 A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease Status RECRUITING Phase PHASE2
NCT06975878 Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06975865 The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease Status RECRUITING Phase PHASE3
NCT06975722 A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis Status RECRUITING Phase PHASE2
NCT06968975 Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP) Status RECRUITING Phase N/A
NCT06958536 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease Status RECRUITING Phase PHASE2
NCT06949358 A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France Status COMPLETED Phase PHASE2
NCT06941870 Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy Status RECRUITING Phase PHASE4